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10% at 270 days.
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Objectives: Although genetic inﬂuences in abdominal
aortic aneurysm (AAA) are clear, no major genetic cause
has been identiﬁed so far. In this study we investigated
whether familial AAA (fAAA) is associated with a familial
predisposition for atherosclerosis.Methods: Patients were derived from a prospective
database including AAA patients treated between 2004
and 2012. Family history was obtained by written ques-
tionnaire (93% response rate). fAAA was deﬁned as having
at least one 1st-degree relative with an aortic aneurysm. A
standardized ultrasound measurement of the common
carotid intima-media thickness (CIMT), a marker for
generalized atherosclerosis, was performed and clinical
characteristics (demographics, cardiovascular risk factors,
comorbidities, and medication use) were recorded. Multi-
variable linear and logistic regression analyses were used
to calculate the association of CIMT and fAAA vs sporadic
AAA (spAAA).
Results: A total of 461 AAA patients (85% men, age
70 6 8) were included in the study. 103 (22%) patients
were classiﬁed as fAAA and 358 patients as spAAA. The
mean CIMT in patients with fAAA was 0.89 6 0.24mm
vs 1.00 6 0.29 mm in patients with spAAA (P ¼ .001).
Adjustment for the clinical characteristics showed a mean
difference in CIMT of 0.09 mm (95% CI, 0.03-0.16;
P ¼ .007). Furthermore, a lower CIMT was independently
associated with fAAA (Fig).Conclusions: The CIMT was lower in patients with
fAAA compared to patients with spAAA, suggesting that
fAAA is not related to a genetic predisposition for
atherosclerosis.
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Objectives: Efﬁcacy of carotid surgery (CEA) in asymp-
tomatic patients is subject of intense debate. Biomarkers are
required to select those who will most likely beneﬁt from
CEA for their asymptomatic carotid stenosis (ICAS) despite
advanced age.
Aim: In this study we assessed plasma total homocys-
teine (thcy), a widely acknowledged cardiovascular risk
factor, as stratifying biomarker to improve prediction of
postoperative survival beyond the age of 75 years.
Methods: Single centered, non-randomized, open-
labeled prospective cohort-study from 2003 to 2012.
214 consecutive patients (88 female, 126 male, mean
age 71 years) undergoing carotid surgery for their asymp-
tomatic high-grade stenosis of their internal carotid
stenosis (ICAS) were observed (mean observation period
8.5 years) for the occurrence of death after CEA as
primary end point. (Local Ethics Committee nr: 04-
067-0604) Statistics: Mann-Whitney-U Test was used
for comparison of medians, Cox-Regression for estimating
thcy-associated hazard ratios. Classic cardiovascular risk
factors were used for computation of prognostic indices
(PI). Cumulative survival probability of PI-based quintiles
was estimated by Kaplan-Meier Curves. The effect of the
prognostic model was evaluated by the actual percental
distribution of age groups age (</>75 years) over PI-
based quintiles.
Results: Thcy had a signiﬁcant effect on postoperative
survival. Thcy-based quintiles of prognostic indices showed
a better prediction of the patients’ 5-year (60 months)
survival than age alone. This caused reclassiﬁcation of 17
patients (20.2%) older than 75 years as ﬁt for surgery,
but also indicated a high risk for 19 patients (14.6%)
younger than 75 years. In 79.8% of over 75 year old
patients, statistically, CEA could not be advised due to
signiﬁcantly reduced survival.
Conclusions: Homocysteine levels, along with other
major CVRF, allow a better risk stratiﬁcation of elderly
patients undergoing CEA for their asymptomatic ICAS
than an age cut-off of 75 years.
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Objectives: To evaluate operative results and short-
term outcomes in early vs late experience after fenestrated
endovascular aortic repair (f-EVAR) in two tertiary Euro-
pean referral centers.
Methods: All patients treated in (A) Malmö, Sweden
and in (B) Lille, France with f-EVAR for abdominal aortic
aneurysm (AAA) were prospectively enrolled in a comput-
erized database. Early experience was deﬁned as the ﬁrst
50 patients treated at each center. Data from early and
late experience was retrospectively analyzed and
compared for differences in operative results and one-
year outcomes.
Results: Early experience covered 4.7 years in A and
4.5 years in B with late experience covering 5.6 years in
A and 3.7 years in B. A total of 288 patients were
included without signiﬁcant differences in comorbidities,
gender (male, 88%), age (72 6 7 years) and preoperative
AAA diameter (59 6 10 mm) between the groups. In
the later phase, stent graft conﬁguration was more
complex due to increased number of fenestrations/scal-
lops incorporated in the graft design (2.7 6 0.8 vs 3.2 6
0.7; P < .001). Despite this, contrast volume and radia-
tion time decreased by 27% and 20% respectively while
procedure time remained unchanged (279 6 123
minutes). At one year, AAA diameter decreased ($5
mm) in 54% of patients in the early group and in 62%
of patients in the late group. Similar results for aneurysm
expansion were 5% and 2% respectively. No differences
were found in operative mortality (2.1%), late mortality
(3.8%), reintervention rate (10.5%), type I endoleaks
(1.1%) or target vessel patency (98.4%) at one-year
follow-up.
Conclusions: With increasing experience, f-EVAR
design has become more complicated with more visceral
vessels targeted for better proximal seal while operative risk
still remains low. This has resulted in a larger portion of
aneurysms decreasing in diameter during follow-up. Simulta-
neously, radiation time and contrast volume has been
reduced with possible long-term beneﬁts for the patient.
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